openPR Logo
Press release

Postpartum Depression Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Key Players: SAGE Therapeutics, GH Research, Bristol-Myers Squibb

10-04-2024 05:15 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Postpartum Depression Market

Postpartum Depression Market

(Albany, USA) DelveInsight's "Postpartum Depression Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Postpartum Depression, historical and forecasted epidemiology as well as the Postpartum Depression market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Postpartum Depression market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Postpartum Depression Market Forecast
https://www.delveinsight.com/sample-request/postpartum-depression-ppd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key facts of the Postpartum Depression Market Report
• The Postpartum Depression market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In 2023, the market size for postpartum depression across the 7MM was estimated at USD 260 million.
• By 2034, ZURZUVAE is anticipated to generate approximately USD 600 million in revenue from the postpartum depression therapeutics market across the 7MM.
• Among the EU4 countries and the UK, the UK had the largest postpartum depression market size, approximately USD 25 million in 2023.
• In 2023, Japan's postpartum depression market size was approximately USD 20 million, with a moderate growth expected by 2034.
• In 2023, the total number of diagnosed postpartum depression cases across the seven major countries was approximately 1,310,000.
• In 2023, the total number of diagnosed postpartum depression cases in the EU4 countries and the UK was approximately 460,000.
• In 2023, the United States had the highest number of diagnosed postpartum depression cases among the seven major markets, totaling approximately 720,000, followed by the UK.
• In 2023, Japan had approximately 126,000 diagnosed prevalent cases of postpartum depression.
• ZURZUVAE (zuranolone) and ZULRESSO (brexanolone) are the only approved treatments for postpartum depression (PPD). ZULRESSO is given as a continuous intravenous (IV) infusion, while the recommended dosage for ZURZUVAE is 50 mg taken orally for 14 days. Leading companies working on new PPD therapies include Sage Therapeutics, Marinus Pharmaceuticals, Lipocine, and Brii Biosciences.
• Key Postpartum Depression Companies: SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research, Bristol-Myers Squibb, and others
• Key Postpartum Depression Therapies: Zuranolone(SAGE-217), BRII-296, RE104, GH001, Brexanolone, aripiprazole, and others
• The Postpartum Depression epidemiology based on gender analyzed that PPD majorly affects females but a small proportion of males can also experience depression post-pregnancy
• The Postpartum Depression market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Postpartum Depression pipeline products will significantly revolutionize the Postpartum Depression market dynamics.

Postpartum Depression Overview
About 10-15% of women have postpartum depression (PPD), which is the most prevalent non-psychotic pregnancy consequence. As a result, PPD is a serious public health issue that affects both women and their families. It is generally known that there is a higher chance of major mood problems developing during the postnatal period.

Get a Free sample for the Postpartum Depression Market Report
https://www.delveinsight.com/report-store/postpartum-depression-ppd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Postpartum Depression Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Postpartum Depression Epidemiology Segmentation:
The Postpartum Depression market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Postpartum Depression
• Prevalent Cases of Postpartum Depression by severity
• Gender-specific Prevalence of Postpartum Depression
• Diagnosed Cases of Episodic and Chronic Postpartum Depression

Download the report to understand which factors are driving Postpartum Depression epidemiology trends @ Postpartum Depression Epidemiology Forecast
https://www.delveinsight.com/sample-request/postpartum-depression-ppd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Postpartum Depression Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Postpartum Depression market or expected to get launched during the study period. The analysis covers Postpartum Depression market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Postpartum Depression Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Postpartum Depression Therapies and Key Companies
• Zuranolone(SAGE-217): SAGE Therapeutics
• BRII-296: Brii Biosciences Limited
• RE104: Reunion Neuroscience
• GH001: GH Research
• Brexanolone: Sage Therapeutics
• aripiprazole: Bristol-Myers Squibb

Discover more about therapies set to grab major Postpartum Depression market share @ Postpartum Depression Treatment Market
https://www.delveinsight.com/sample-request/postpartum-depression-ppd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Postpartum Depression Market Drivers
• ZULRESSO starts working within 2-3 days of the administration, drastically improving the response rates compared to conventional therapies
• Therapies like BRII-296 and LPCN-1154 are in early stages of clinical development and their approval in future can help the PPD therapeutic market grow tremendously.

Postpartum Depression Market Barriers
• Limited therapies are available for treating and diagnosing PPD, thus providing profitable opportunities for emerging therapies
• Increasing research and development to establish the pathophysiology and recent advancement in the diagnosis gives alucrative opportunity for the PPD market

Scope of the Postpartum Depression Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Postpartum Depression Companies: SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research, Bristol-Myers Squibb, and others
• Key Postpartum Depression Therapies: Zuranolone(SAGE-217), BRII-296, RE104, GH001, Brexanolone, aripiprazole, and others
• Postpartum Depression Therapeutic Assessment: Postpartum Depression current marketed and Postpartum Depression emerging therapies
• Postpartum Depression Market Dynamics: Postpartum Depression market drivers and Postpartum Depression market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Postpartum Depression Unmet Needs, KOL's views, Analyst's views, Postpartum Depression Market Access and Reimbursement

To know more about Postpartum Depression companies working in the treatment market, visit @ Postpartum Depression Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/postpartum-depression-ppd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Postpartum Depression Market Report Introduction
2. Executive Summary for Postpartum Depression
3. SWOT analysis of Postpartum Depression
4. Postpartum Depression Patient Share (%) Overview at a Glance
5. Postpartum Depression Market Overview at a Glance
6. Postpartum Depression Disease Background and Overview
7. Postpartum Depression Epidemiology and Patient Population
8. Country-Specific Patient Population of Postpartum Depression
9. Postpartum Depression Current Treatment and Medical Practices
10. Postpartum Depression Unmet Needs
11. Postpartum Depression Emerging Therapies
12. Postpartum Depression Market Outlook
13. Country-Wise Postpartum Depression Market Analysis (2020-2034)
14. Postpartum Depression Market Access and Reimbursement of Therapies
15. Postpartum Depression Market Drivers
16. Postpartum Depression Market Barriers
17. Postpartum Depression Appendix
18. Postpartum Depression Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Trending Reports:
• Pharmaceutical Consulting Companies: https://www.delveinsight.com/consulting
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/infographics/progressive-multifocal-leukoencephalopathy-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-nec-epidemiology-forecast
• Chronic Progressive Multiple Sclerosis Market: https://www.delveinsight.com/report-store/chronic-progressive-multiple-sclerosis-market
• Brain Aneurysm Stents Market: https://www.delveinsight.com/report-store/intracranial-stents-market
• Chronic Hepatitis Delta Virus Market: https://www.delveinsight.com/infographics/hepatitis-d-market
• Post-transplant Lymphoproliferative Disease Market: https://www.delveinsight.com/report-store/post-transplant-lymphoproliferative-disorder-market
• Filgrastim Biosimilar Insight: https://www.delveinsight.com/report-store/filgrastim-biosimilar-insight
• Peripheral Neuropathic Pain Market: https://www.delveinsight.com/report-store/peripheral-neuropathic-pain-market
• Chronic Gout Market: https://www.delveinsight.com/report-store/chronic-refractory-gout-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Allergic Asthma Due To Dermatophagoides Farinae Market: https://www.delveinsight.com/report-store/allergic-asthma-due-to-dermatophagoides-farinae-market
• Epithelial Ovarian Cancer Market: https://www.delveinsight.com/report-store/ovarian-cancer-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Adrenogenital Syndrome Market: https://www.delveinsight.com/report-store/congenital-adrenal-hyperplasia-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Cardiac Resynchronization Therapy Device Market: https://www.delveinsight.com/report-store/cardiac-resynchronization-therapy-market
• Gout Market: https://www.delveinsight.com/report-store/gout-market
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market
• Allergic Rhinoconjunctivitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Cerebral Aneurysm Market: https://www.delveinsight.com/report-store/intracranial-aneurysms-market-insight
• Head And Neck Squamous Cell Carcinoma Market: https://www.delveinsight.com/report-store/head-and-neck-cancer-hnc-market
• Radioligand Therapies Market: https://www.delveinsight.com/report-store/radioligand-therapies-market-forecast
• Surgical Site Infections Market: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market
• Wound Closure Devices Market: https://www.delveinsight.com/report-store/wound-closure-device-market
• Biliary Atresia Market: https://www.delveinsight.com/report-store/biliary-atresia-market
• Binge Eating Disorder Market: https://www.delveinsight.com/report-store/binge-eating-disorders-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postpartum Depression Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Key Players: SAGE Therapeutics, GH Research, Bristol-Myers Squibb here

News-ID: 3677496 • Views:

More Releases from DelveInsight Business Research

Autistic Disorder Pipeline 2025: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight
Autistic Disorder Pipeline 2025: In-depth Clinical Trials Analysis and Emerging …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Autistic Disorder pipeline constitutes 25+ key companies continuously working towards developing 25+ Autistic Disorder treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Autistic Disorder Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also
Hypovolemic Shock Market Growth to Accelerate in Forecast Period (2024-2032), DelveInsight Analyzes
Hypovolemic Shock Market Growth to Accelerate in Forecast Period (2024-2032), De …
The Hypovolemic Shock market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hypovolemic Shock pipeline products will significantly revolutionize the Hypovolemic Shock market dynamics. DelveInsight's "Hypovolemic Shock Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Hypovolemic Shock, historical and forecasted epidemiology as well as the Hypovolemic Shock market trends in the United
Chronic Insomnia Market to Expand Significantly by 2034, States DelveInsight Report
Chronic Insomnia Market to Expand Significantly by 2034, States DelveInsight Rep …
The Chronic Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics. DelveInsight's "Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States,
Chronic Spontaneous Urticaria Market Growth Projections 2024-2034: DelveInsight Analysis
Chronic Spontaneous Urticaria Market Growth Projections 2024-2034: DelveInsight …
DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as well as the Chronic Spontaneous Urticaria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Chronic Spontaneous Urticaria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Spontaneous Urticaria

All 5 Releases


More Releases for Postpartum

Postpartum Care Services Market 2025-2033
London, UK - September 2025 | Strategic Revenue Insights Inc. The Postpartum Care Services market is rapidly emerging as a critical sector within the global healthcare industry, driven by the increasing focus on maternal health and well-being. As families recognize the importance of comprehensive postpartum support, demand for specialized services such as in-home care, hospital-based care, telehealth, and lactation consulting has surged. Forecasts indicate that the market is poised to
Key Trend Reshaping the Postpartum Depression Market in 2025: Companies Innovati …
What Are the Projections for the Size and Growth Rate of the Postpartum Depression Market? The postpartum depression market has witnessed exponential growth in recent years. It will grow from $12.15 billion in 2024 to $16.09 billion in 2025, at a CAGR of 32.4%. The historic growth can be attributed to increased awareness about maternal mental health, research progress, public health initiatives, and a rise in screenings. The postpartum depression market is
Postpartum Depression Global Market Report 2024 - Postpartum Depression Market S …
The Business Research Company recently released a comprehensive report on the Global Postpartum Depression Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The postpartum depression market
Elevate Your Strategy: Insights on Postpartum Depression Market Potential
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a renowned Market research firm, introduces its latest research report on the 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭, providing a detailed guide for businesses seeking growth progression. This report is meticulously crafted to aid in investment decisions, offering crucial insights and encouraging strategic investment discretion for new entrants aiming for seamless Market penetration. 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐑𝐞𝐩𝐨𝐫𝐭 https://growthmarketreports.com/request-sample/4187 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭: The global
Postpartum Hemorrhage Treatment Market Trends | 2022 | Industry Analysis
The global postpartum hemorrhage treatment market size was valued at USD 802.34 in 2021, growing at a CAGR of 5.3% during the forecast period 2022-28. During the postpartum hemorrhage surgical operation, postpartum hemorrhage therapy devices are essential medical equipment. The severe blood loss that occurs in the initial few hours following childbirth is known as postpartum hemorrhage, and it can even result in the death of the mother. It is
Demand: Postpartum Hemorrhage Devices Market to Fuel Revenue Growth
The global postpartum hemorrhage devices market is estimated to surpass $1,170.3 million by 2027, exhibiting a CAGR of 5.2% from 2020 to 2027. The report aims to cater scrupulous analysis of the global postpartum hemorrhage devices market by methodically reviewing different facets of the market such as key segments, market dynamics, regional market circumstances, investment opportunities, and top players operating in the market. In addition, the report offers insights on the current